Advancing Innovation
Prescreening and Safety Simplify Complex Vaccine Study
Prescreening and safety measures simplified a Phase II study of a four-dose vaccine that required multiple rating scales. All 80 patients received four injections over 24 weeks and then were followed for 65 weeks
